October 14, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for June 24, 2004 Subscribe to this News Feed  
 

FDA approves Botox for Sweating

Download this press release as an Adobe PDF document.

New FDA approval of Botox use for excessive sweating can leave other tratments dry. Dr. Simon Ourian, Chief reasearcher for Epione Medial Corporation in Beverly Hills, number one botox clinic in the world, is always at the forefront of medial advances. As the leading user of Botox, Dr. Ourian is the authority in the new uses of Botox, and he has been using Botox to treat Excessive sweating for the past five years.

Beverly Hills, CA (PRWEB) July 20, 2004 -- Doctor Simon Ourian's office is one of the most popular Botox practices in the world. He is a pioneer in the treatment of hyperhidrosis, or excessive sweating, by Botox. The FDA originally approved botulinum toxin type A ( Botox) in 1989 for the treatment of two types of eye-muscle problems — including crossed eyes. Since then, doctors have used injections to treat migraine and tension headaches; involuntary muscle contractions (dystonia) and spasms; and some localized pain conditions, including pain from shingles. Now one of the biggest Botox success stories is treatment of excessive sweating, or hyperhidrosis,

Hyperhidrosis

In a society that demands that you "never let them see you sweat," the excessive sweating condition known as hyperhidrosis can be a debilitating and life-inhibiting disorder if left untreated. Hyperhidrosis tends to first occur during the early adolescence. It causes much of its social, psychological, emotional, and physical impairments because of its conspicuous locations: on the palms, underarms, and soles of the feet. At the same time, the amount of sweat that is produced is often too difficult to conceal.

The Cause

Excessive sweating, or hyperhidrosis, is caused by stimulation of the sweat glands by nerve endings which descend from higher centers in the brain. These nerves respond to emotional stresses; like intimate social situations, public speaking, physical stresses, and increased body temperature that comes with exercise or hot humid weather.

Quick Relief
"Botox injections are used for localized hyperhidrosis, in which the excessive sweating is limited to the armpits or palms and occasionally the soles of the feet." says Ourian. Roughly 1%–3% of the population has the problem. About 30% of sufferers say that other family members are also affected, suggesting that there might be a genetic component to the condition.

A cure for sweat?

Hyperhidrosis goes far beyond the occasional bouts of nervous sweating we've all experienced", says Dr. Ourian, "My patients have to change their shirts several times a day, wear colors that dont show sweat stains, and carry around paper towels to continually dab their palms." Severe cases can seriously affect work and social life.

The treatment for the underarms and palms involves 40–50 injections of Botox and takes less than half an hour. The needle is very fine, so they dont hurt very much. But injections into the palms often do hurt, and a local anesthetic is needed." we use a cooling device that causes localized numbing" says doctor Ourian.

A study of about 200 axillary (armpit) hyperhidrosis patients in the June 2003 Archives of Dermatology found that the average time between injections was 7 months.

The FDA approval of Botox for hyperhidrosis be the best news for Hyperhidrosis sufferers for years to come.

Dr. Ourian's Epione Medical Center, located in Beverly Hills Golden Triangle, is among the world's most comprehensive and state-of-the-art laser and aesthetic surgery centers. Epione provides the most innovative technology available for skin, hair and body contouring. Dr. Ourian has been a pioneer for laser technology and non-invasive aesthetic procedures for acne, skin discoloration, wrinkles and breast augmentation. For further information, please contact 800-828-6466 or visit www.epione.com.

# # #


See the original story at: http://www.prweb.com/releases/2004/06/prweb136239.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Simon Ourian
EPIONE MEDICAL CO.
310-271-6506
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright